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Abstract
Intracardiac thrombus in Behçet's disease is an extremely rare manifestation. We report two such
cases. A 20-year-old man presented with dyspnoea, cough and haemoptysis. Right heart thrombus
associated with pulmonary artery aneurysm and thromboembolism was identified by helical CT and
transoesophageal echocardiography. The second case was a 29-year-old male admitted for fever
and chest pain. A diagnosis of right atrial thrombosis associated with pulmonary embolism and
hyperhomocysteinemia was made. Due to the absence of haemodynamic compromise, medical
management consisting of immunosupressive and anticoagulation therapy was adopted which
resulted in complete dissolution of the thrombus with dramatic clinical improvement in both cases
of clinical status.
Conclusion: intracardiac thrombus is a rare complication of Behçet's disease. As shown in our
patients, medical treatment should be considered as the first line.
Background
Behcet's disease (BD) is a multisystemic inflammatory
disease with a clinical spectrum that has greatly expanded
since it was first described in 1937 as a triple complex of
recurrent oral genital ulcers and uveitis. Cardiac involve-
ment is extremely rare and often associated with poor
prognosis [1]. We report two patients with a large intrac-
ardiac thrombus (ICTs) out of a series of 130 patients with
BD.
Case reports
Case 1
A 20-year-old Tunisian man with a three weeks history of
dyspnoea, cough and haemoptysis was admitted. At the
age of 18, he had suffered from painful oral and genital
ulcerations and polyarthralgias. At that time, examination
revealed bilateral papillary oedema and brain magnetic
resonance imaging showed superior sagittal and left lat-
eral thromboses. The patient was given oral prednisone at
the dose of 1 mg/kg/day that was tapered gradually and
colchicine 1 mg/day in addition to acenocoumarol to
maintain International Normalized Ratio between 2 and
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3. These medications were discontinued per the patient 7
months later which resulted in the recurrence of aphtous
ulcerations and papulopustular eruptions episodes.
On physical examination the patient had fever, face and
neck oedema, prominent superficial thoracic venous col-
laterals, and pseudofolliculitis lesions. There was evidence
of penile and scrotal scarring and minor aphthae on the
buccal mucosa. Blood pressure was 110/80 mm Hg and
pulse rate 100/min.
As to laboratory tests, haemoglobin concentration was of
9 g/dl, erythrocyte sedimentation rate of 60 mm/hr and C
reactive protein concentration of 19 mg/l (normal < 2 mg/
l). Renal and liver function tests were normal. Levels of
serum IgG and IgM anticardiolipin, protein C, protein S,
antithrombine III and total homocysteine were within the
normal range. Electrocardiogram showed sinus rhythm
tachycardia with no other abnormalities. Chest X-ray
demonstrated hilar enlargement. Transthoracic and tran-
soesophageal echocardiography showed multiple cardiac
masses, one in the right atrium protruding through the tri-
cuspid valve and two in the right ventricle (Figure 1 – see
Additional file 1). Helical computed tomography (CT)
showed multiple thrombi in both right atrium and ventri-
cle extending into the superior vena cava. There was
innominate and brachiocephalic vein occlusion, it also
showed bilateral pulmonary embolism and multiple pul-
monary infarcts in the lower lobe of the lungs. A large (14
mm in diameter) aneurysm located in the right basal seg-
mental arteries (Figure 2 – see Additional file 2). We opted
for a treatment based on low molecular weight heparin
twice daily then oral anticoagulant, 1 gr of methyl pred-
nisolone per day for 3 days, 1 mg/kg/day of oral, then
tapered over 3 weeks and 1 g pulse cyslophosphamide
monthly associated with colchicine 1 mg/day.
Two weeks later, oedema of the chest and neck has com-
pletely resolved. Thrombus size has substantially
decreased. Nine months after discharge, no cardiac masses
were detected by echocardiography and CT scan showed
no evidence of previously mentioned thromboses with a
complete disappearance of pulmonary aneurysm.
Case 2
A 29-year-old Tunisian man with a two-month history of
fever of unknown origin, weight loss and inspiratory tho-
racic pain was admitted. He had suffered from both geni-
tal and oral ulcers over five months. The initial physical
examination revealed a temperature of 38°C, multiple
pseudofolliculitis, oral and scrotal ulcerations. Laboratory
tests on admission revealed: haemoglobin of 13 g/dl,
erythrocyte sedimentation of 105 mm/hr and C reactive
protein concentration of 204 mg/l. The tests looking for
antiphospholipid antibodies, protein C, protein S and
Transthoracic echocardiography: in apical four chamber view Figure 1
Transthoracic echocardiography: in apical four chamber 
view. (VD: right ventricle, VG: left ventricle, OD: right 
atrium, OG: left atrium) image of one thrombus in the right 
atrium, and two thrombi in the right ventricle (a), tran-
soesophageal echocardiography showing a large thrombus 
(b), after treatment, complete resolution of the thrombus 
(c).Thrombosis Journal 2005, 3:9 http://www.thrombosisjournal.com/content/3/1/9
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antithrombine III deficiencies were negative. The plasma
total homocysteine level was 27 µmol/l (normal < 10
µmol/l). HLAB5 and pathergy tests were positive. Electro-
cardiogram showed sinus rhythm tachycardia, and chest
X-ray was normal. Transoesophageal echocardiography
revealed a cardiac mass in the right atrium of 20/23 mm
size attached into atrial septum protruding through the
tricuspid valve into the right ventricle (Figure 3 – see Addi-
tional file 3). These findings were confirmed by CT scan
that also showed a partial obstruction of the terminal por-
tion of the inferior vena cava and thrombosis of the left
lobar pulmonary artery with multiple pulmonary infarcts.
We started treatment with intravenous heparin then oral
anticoagulant, 1 gr of methyl prednisolone per day for 3
days, 1 mg/kg/day of oral, which was tapered gradually
and 1 g pulse of cycslophosphamide monthly associated
with colchicine 1 mg/day. Consequently, the thrombus in
the right atrium has substantially decreased in size. At five
months follow-up, a complete resolution of the thrombi
in the right atrium, vena cava and pulmonary artery tree
was observed.
Discussion
Cardiac manifestations in BD which are indication of
poor prognosis were reported to occur in about 1 – 5% of
cases [1]. They consist of cardiomegaly, endocarditis or
pericarditis and less commonly of myocardial infarction
and myocarditis [2,3]. Association with intracardiac
thrombus which is a serious complication, is even more
rare, up to this date, less than 50 cases have been reported
so far [4-8].
Our patients fulfilled the proposed criteria of the interna-
tional study group for BD [9], with active disease (two or
more active clinical features related to BD). Two interest-
ing issues about these cases should be emphasized: first,
the unusual presentation of BD with ICTs and pulmonary
thromboembolism, second, the favourable response to
medical management. The association of intracardiac
thrombosis, with the less uncommon pulmonary arteritis
and vena cava thrombosis was described for the first time
by Houman [10] and reported in only few cases so far [4].
In our patients, we can reasonably exclude retrospectively
myxoma and endocarditis, in view of the mass resolution
on immunosuppressive and anticoagulation therapy.
Biopsy carries an excessive risk [2], but has the advantage
of providing material for histological examination. The
organized thrombus usually contained an inflammatory
cell infiltrate composed of a mixture of granulocytes and
mononuclear inflammatory cells or predominantly lym-
phocytes. The histologic descriptions of the thrombi may
be dependent on the biopsy timing [4]. We did not per-
form a right ventricular biopsy in our patients.
The pathogenic mechanism underlying thrombotic ten-
dency in patients with BD is not well known. It is however
believed to be due to endothelial cell ischemia or disrup-
tion that leads to enhancement of platelet aggregation
[11]. Also decreased release of vascular tissue plasmino-
gen activator has been reported in systemic and cutaneous
vasculitis [12]. Another possible pathogenic mechanism
of thrombosis in BD is attributed to the presence of anti
phospholipid antibodies which is reported to be present
in 18% of cases [13,14]. Elevated Von Willebrand factor
antigen levels have recently been demonstrated [15].
Hyperhomocysteinemia was reported to be present in
patients with BD and was associated with increased risk of
vascular thrombosis [16], which may have contributed to
cardiac thrombus formation in our second patient. To the
best of our knowledge this association has not been previ-
ously reported.
Chest helical computed tomography demonstrating a single  (14 mm) right main pulmonary artery aneurysm and image of  thrombi in the right heart (a), diffuse venous collateral ves- sels and superior vena cava thrombosis (b) Figure 2
Chest helical computed tomography demonstrating a single 
(14 mm) right main pulmonary artery aneurysm and image of 
thrombi in the right heart (a), diffuse venous collateral ves-
sels and superior vena cava thrombosis (b).Thrombosis Journal 2005, 3:9 http://www.thrombosisjournal.com/content/3/1/9
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Diagnosis may be confirmed either at necropsy or after
surgery. In our cases, this complication of BD was diag-
nosed by echocardiography. Other imaging modalities
including CT scan and MRI can show vascular complica-
tions and give information concerning the lung paren-
chyma. The management of ICTs is still controversial [4].
Surgical removal has the advantage of providing material
for histological examination; medical management how-
ever was associated with a better outcome. Mogulkoc's
review about 24 cases of ICTs, surgery was unsuccessful in
4/12 cases, whereas complete resolution of the thrombus
on medical therapy was observed in 7/8 [4].
Anticoagulant or thrombolytic therapy was the first line
treatment of intracardiac thrombus [4]. In the presence of
pulmonary aneurysms this therapy could lead to fatal hae-
moptysis especially in bilateral and large aneurysms. In
our first case ICTs was associated with multiple venous
thrombi and only a small aneurysm with no haemody-
namic compromise. Considering the risk of surgical treat-
ment we preferred a conservative approach with
immunosuppressive and anticoagulant therapy.
We conclude that thrombi especially in the right heart cav-
ities can be present in BD without causing specific symp-
toms but can lead to pulmonary embolism. Early
echocardiography seems advisable to detect the presence
of cardiac involvement and medical therapy can be effec-
tive in the resolution of ICTs in the setting of BD.
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